Newer variant-specific bivalent vaccines offer on average 1.6 times better immunity against COVID-19 than the original, single-strain “ancestral” vaccines, new research by UNSW’s Kirby institute published today in Nature Medicine shows.
Newer variant-specific bivalent vaccines offer on average 1.6 times better immunity against COVID-19 than the original, single-strain “ancestral” vaccines, new research by UNSW’s Kirby institute published today in Nature Medicine shows.
Leave A Comment